AR-GE

LINACOL Medikal has completed the CE certification of all its products in January 2014 and has been active and uninterrupted in the Turkish and foreign markets for 3.5 years.

In the middle of 2017, with its competent sales personnel, it managed to reach the number of 200 dealers registered in 70 different provinces, approved on behalf of LINACOL in the Ministry of Health system throughout Turkey. Currently, LINACOL's market share in Turkey can be expressed as 70% in the shunt and drainage systems market.

LINACOL Medikal is increasing its brand awareness and trust in the local market day by day. The local market share of LINACOL Medikal, which has a price advantage compared to foreign competitors during the tender stages of the Ministry of Health, is targeted to reach 80% by the end of 2017. LINACOL Medikal foresees increasing its overseas sales in 2017, especially to the Middle East and Eastern Europe regions.